Home » Grants » Translational Research Program (primary immunodeficiency worldwide)

Translational Research Program (primary immunodeficiency worldwide)

The Translational Research Program from the Jeffrey Modell Foundation supports innovative, translational research projects on primary immunodeficiency with the potential to lead to clinical applications. Research projects in the following areas are particularly encouraged:

  • Novel primary immunodeficiency defects
  • Innovative approaches to early diagnosis
  • Novel therapeutic strategies
  • Translational impact on patient health (i.e. how a patient will benefit)
  • Reach of the proposed project (i.e. how many patients might benefit)
  • Projects that currently do not have funding and would be otherwise difficult to advance without this award

Applications are open to primary immunodeficiency researchers at all career stages around the world. The Program provides up to 250,000 USD in funding for projects spanning up to 2 years.

Letters of intent are due on March 14, 2023 and invited full applications are due on July 6, 2023.

Challenge: Rare Diseases

Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.

Sign-up for the
monthly research
funding newsletter

You can unsubscribe at any time.